Godavari Biorefineries Ltd (GODAVARIB) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Godavari Biorefineries Ltd on NSE and BSE, with an AI summary of each filing.
Press release for the quarter and half year ended 30th September, 2026
Press Release · 05 Nov 2026, 1:37 am
Godavari Biorefineries Reports Q2 FY27 Results with Operating Profit Turnaround Godavari Biorefineries reported a 26.6% YoY rise in consolidated total revenue to Rs 549.8 Cr for Q2 FY27 ended 30th Sep'26. EBITDA turned positive to Rs 10.9 Cr (2.0% margin) from a negative Rs 4.4 Cr in Q2 FY26, while net loss narrowed to Rs 15.2 Cr from Rs 41.6 Cr. Growth was driven by the Bio-Based Chemicals segment, where revenue climbed 38.8% YoY to Rs 204.2 Cr and EBITDA rose 47.3% to Rs 22.1 Cr, offsetting ongoing feedstock and regulatory headwinds in the sugar and ethanol division.
Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026
Financial Result · 05 Nov 2026, 1:27 am
Godavari Biorefineries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Financial Result · 05 Nov 2026, 1:23 am
Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2026
Outcome · 05 Nov 2026, 1:03 am
Godavari Biorefineries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 54,924 (+27.5% YoY | -1.5% QoQ) ■ EBITDA: 1,033 (Loss to Profit YoY | +1880.7% QoQ) ■ EBITDA Margin (%): 1.9 (Loss to Profit YoY | +179 bps QoQ) ■ PAT: -1,524 (+63.4% YoY | +21.1% QoQ) ■ EPS (INR): -2.98 (+63.3% YoY | +21.2% QoQ) Godavari Biorefineries Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) Segmental Performance Sugar ■ Revenue: 21,247 (+18.6% YoY | -16.2% QoQ) ■ EBIT: -1,531 (+15.7% YoY | +4.6% QoQ) ■ EBIT Margin (%): -7.2 (+294 bps YoY | -87 bps QoQ) Cogeneration ■ Revenue: 1,330 (+73.0% YoY | -45.7% QoQ) ■ EBIT: -978 (+6.9% YoY | -22.6% QoQ) ■ EBIT Margin (%): -73.5 (+6308 bps YoY | -4093 bps QoQ) Bio based Chemicals ■ Revenue: 20,422 (+38.8% YoY | +21.1% QoQ) ■ EBIT: 1,877 (+55.3% YoY | +18.5% QoQ) ■ EBIT Margin (%): 9.2 (+97 bps YoY | -20 bps QoQ) Distillery ■ Revenue: 13,129 (+29.4% YoY | -15.6% QoQ) ■ EBIT: 453 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 3.5 (Loss to Profit YoY | Loss to Profit QoQ) Unallocated ■ Revenue: 1,087 (+37.6% YoY | -3.5% QoQ) ■ EBIT: -257 (-145.4% YoY | -31.1% QoQ) ■ EBIT Margin (%): -23.7 (-1039 bps YoY | -625 bps QoQ)
GODAVARI BIOREFINERIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 am
Earning call for Q2 and H1 of FY 27
Intimation · 06 Nov 2026, 11:00 am
Godavari Biorefineries Schedules Q2 and H1 FY27 Earnings Call for November 2026 Godavari Biorefineries Limited will host its earnings conference call on 6th Nov'26 at 11:00 AM IST to discuss financial and operational performance for the quarter and half-year ended 30th Sep'26. Key management speakers include Chairman & Managing Director Samir Somaiya and DGM of Investor Relations & Finance Ashish Sinha. Universal dial-in numbers are +91 22 6280 1550 and +91 22 7115 8378, alongside international toll-free lines for the USA, UK, Singapore, and Hong Kong. No unpublished price-sensitive information will be shared.
GODAVARI BIOREFINERIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Godavari Biorefineries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 04 Nov 2026, 5:30 am
Godavari Biorefineries Schedules Board Meeting on 4th Nov'26 for Q2 Results Godavari Biorefineries Limited has informed exchanges that its Board of Directors will meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives from 1st Oct'26 until 48 hours after the declaration of the financial results.
The US patent office has approved our patent application entitled "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer"
Others (Uncategorized) · 14 Oct 2026, 11:32 pm
Godavari Biorefineries Secures US Patent for Novel Cancer Treatment Compounds Godavari Biorefineries Limited has been granted a US patent for "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER," as disclosed on 14th Oct'26. The patent protects a novel class of compounds engineered to inhibit cancer and cancer stem cells, demonstrating strong therapeutic potential across multiple indications, including breast and prostate cancers. The approval strengthens the company's proprietary oncology pipeline and global intellectual property portfolio.
The Mexican patent office has granted our patent application entitled ''Use of Compounds for Treating Viral Infections''
Others (Uncategorized) · 02 Oct 2026, 2:28 pm
Godavari Biorefineries Secures Mexican Patent for Antiviral Compounds Godavari Biorefineries received a patent grant from the Mexican Patent Office (Patent No. 438818) on 2nd Oct'26 for its application titled "USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS." The patent covers compounds designed to inhibit V-ATPase cellular activity and their application in manufacturing medicaments to treat viral infections. The grant holds a 20-year validity expiring on 10th May'41, strengthening the company's proprietary specialty and healthcare chemical portfolio.
Scrutinizer Report alongwith Voting Results for the AGM held on September 28, 2026
Annual General Meeting · 29 Sept 2026, 10:53 pm
Appointment/Re-appointment of Directors
Change in Management · 28 Sept 2026, 11:48 pm
Godavari Biorefineries Approves Key Board Appointments and Re-Appointments at AGM Shareholders of Godavari Biorefineries approved key board appointments and re-appointments at the 71st AGM on 28th Sep'26. Mr. Samir S. Somaiya was re-appointed as Managing Director for three years effective 1st Apr'27. Mr. Suhas Godage was re-appointed as Whole-Time Director (Executive Director, Works-Sakarwadi) for three years from 1st Apr'27. Mr. Dinesh Sharma was appointed as Whole-Time Director (Executive Director, Works-Sameerwadi) for three years effective 28th Sep'26. Dr. Raman Ramachandran and Mr. Suhas Godage were also re-appointed as directors liable to retire by rotation.
Proceedings of 71st AGM held on Monday, 28th September, 2026
Annual General Meeting · 28 Sept 2026, 10:31 pm
The Company has received a Demand Notice
Others (Uncategorized) · 26 Sept 2026, 7:34 pm
Godavari Biorefineries Receives INR 12.88 Crore Demand Notice From HESCOM Godavari Biorefineries received a demand notice on 25th Sep'26 from HESCOM, Karnataka, totaling INR 12.88 cr for cross-subsidy charges on open access power imported between 2013 and 2016. The demand includes a principal amount of INR 5.91 cr and interest of INR 6.97 cr. The company has classified the principal amount of INR 5.91 cr as a contingent liability, is evaluating the overall financial impact, and plans to pursue appropriate actions with the authority.
The company will officially participate in the Bharat Connect-Arihant Capital virtual conference
Intimation · 23 Sept 2026, 11:59 pm
Godavari Biorefineries to Attend Bharat Connect-Arihant Capital Virtual Conference Godavari Biorefineries Limited announced that its officials will participate in an analyst and institutional investor interaction at the Bharat Connect-Arihant Capital Virtual Conference scheduled for 29th Sep'26. The engagement will be conducted virtually as a group meeting. The company confirmed that discussions will rely strictly on publicly available information, with no unpublished price-sensitive information being shared.
The China Patent Office granted a patent application entitled "Use of Compounds for Treating Viral Infections"
Others (Uncategorized) · 16 Sept 2026, 3:32 pm
Godavari Biorefineries Secures Chinese Patent for Viral Infection Treatment Compounds The Chinese Patent Office has granted a patent to Godavari Biorefineries Ltd for its application entitled "USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS" (Patent No. ZL 2021 8 0048053.9, grant date 15th Sep'26). The patented invention covers the use of specific compounds for inhibiting V-ATPase activity in cells and their application in manufacturing medicaments to treat viral infections.
The European Patent Office has granted a patent application title " A Biofiller for Rubber Reinforcement"
Others (Uncategorized) · 05 Sept 2026, 6:12 pm
Godavari Biorefineries Secures European Patent for Eco-Friendly Rubber Reinforcement Biofiller Godavari Biorefineries received a European patent (EP3313916, published 12th Aug'26) for "A Biofiller for Rubber Reinforcement," disclosed on 5th Sep'26. The patented technology delivers an economic, biodegradable, and eco-friendly biofiller designed to partially replace conventional carbon black in tires and industrial rubber goods without compromising mechanical properties. Featuring a scalable manufacturing process, the innovation offers potential commercial applications across tires, footwear, belts, and bags, establishing cost-saving and environmental value propositions.
71st Annual Report for the FY 2025-26
Others (Uncategorized) · 05 Sept 2026, 12:16 am
Letter to Shareholders of the Company as per Regulations 36 (1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 04 Sept 2026, 11:39 pm
Godavari Biorefineries Schedules 71st AGM and Dispatches Annual Report Notice Godavari Biorefineries Limited will conduct its 71st Annual General Meeting on 28th Sep'26 at 11:30 AM IST via Video Conferencing/OAVM. Under Regulation 36(1)(b) of SEBI Listing Regulations, the company is dispatching letters containing the FY26 Annual Report web link to shareholders without registered email addresses as of the 28th Aug'26 cut-off date. Additionally, physical shareholders are reminded to update mandatory KYC details—including PAN, nomination, and bank credentials—to maintain eligibility for electronic corporate payments and to pursue security dematerialisation.
Notice of 71st Annual General Meeting of the Company to be held on Monday, 28th September, 2026 at 11:30 a.m. through VC/OVAM
Annual General Meeting · 04 Sept 2026, 9:32 pm
Company Received a Show Cause Notice
Others (Uncategorized) · 29 Aug 2026, 2:44 pm
Godavari Biorefineries Receives GST Show Cause Notice from Karnataka Tax Authority Godavari Biorefineries received a show-cause notice on 28 Aug'26 from Karnataka's Commercial Tax Officer regarding alleged ineligible input tax credit for FY23. The total demand comprises Rs. 10.57 crore in GST, Rs. 6.50 crore in interest, and a penalty of Rs. 1.06 crore. The total potential liability, including interest and penalty, amounts to approximately Rs. 18.13 crore. The company is currently evaluating the notice and plans to take appropriate legal steps, including filing replies or appeals.
The company received SCN from the Asst Commissioner of Central GCT
Others (Uncategorized) · 22 Aug 2026, 4:32 am
Godavari Biorefineries Receives ₹17 Crore GST Demand Notice Godavari Biorefineries received a show-cause notice on 21 Aug'26 from the Central GST department regarding non-payment of GST on the supply of Extra Neutral Alcohol (ENA). The total demand is approximately ₹17.02 crore, covering the period from FY22 to Oct'24. The company supplied ENA to Karnataka State Beverages Corporation, classifying it as an "exempted supply." Godavari is currently evaluating the financial impact and plans to take appropriate legal action, including filing replies and appeals against the notice.
Transcript of Earning Call held on 7th August, 2026
Transcript · 13 Aug 2026, 11:37 pm
The European Patent Office has granted our patent application titled "Pharmaceutical Composition and Process to Prepare the same"
Others (Uncategorized) · 11 Aug 2026, 3:39 pm
Godavari Biorefineries Secures European Patent for Novel Anti-Cancer Drug Godavari Biorefineries announced on 11 Aug'26 that the European Patent Office granted it a patent for a "Pharmaceutical Composition and a Process to Prepare the Same". The patent covers a novel anti-cancer composition with a solubilising agent to enhance bioavailability and therapeutic potential, particularly for oral administration. This development strengthens the company's oncology-focused intellectual property portfolio, with specific applications cited for treating breast and prostate cancers. The grant publication date was 15 Jul'26.